EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats

被引:58
|
作者
Sheng, Rui [1 ]
Gu, Zhen-lun
Xie, Mei-lin
Zhou, Wen-xuan
Guo, Ci-yi
机构
[1] Soochow Univ, Sch Med, Dept Pharmacol, Suzhou 215123, Peoples R China
[2] Suzhou Inst Chinese Mat Med, Suzhou 215007, Peoples R China
关键词
epigallocatechin gallate; hypertrophy; apoptosis; oxidative stress; cardiac myocytes;
D O I
10.1111/j.1745-7254.2007.00495.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To investigate the effects of epigallocatechin gallate (EGCG) on pressure overload and hydrogen peroxide (H2O2) induced cardiac myocyte apoptosis. Methods: Cardiac hypertrophy was established in rats by abdominal aortic constriction. EGCG 25, 50 and 100 mg/kg were administered intragastrically (ig). Cultured newborn rat cardiomyocytes were preincubated with EGCG, and oxida-tive stress injury was induced by H2O2. Results: In cardiac hypertrophy induced by AC in rats, relative to the model group, EGCG 25, 50 and 100 mg/kg ig for 6 weeks dose-dependently reduced systolic blood pressure (SBP) and heart weight indices, decreased malondialdehyde (MDA) content, and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activity, both in serum and in the myocardium. Also, treatment with EGCG 50 and 100 mg/kg markedly improved cardiac structure and inhibited fibrosis in HE and van Gieson (VG) stain, and reduced apoptotic myocytes in the hypertrophic myocardium detected by terminal transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay. In the Western blot analysis, EGCG significantly inhibited pressure overload-induced p53 increase and bcl-2 decrease. In H2O2-induced cardiomyocyte injury, when pr ein cu bat ed wi th myocytes for 6-48 h, EGCG 12.5-200 mg/L increased cell viability determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. EGCG also attenuated H2O2-induced lactate dehydrogenase (LDH) release and MDA formation. Meanwhile, EGCG 50 and 100 mg/L significantly inhibited the cardiomyocyte apoptotic rate in flow cytometry. Conclusion: EGCG inhibits cardiac myocyte apoptosis and oxidative stress in pressure overload induced cardiac hypertrophy. Also, EGCG prevented cardiomyocyte apoptosis from oxidative stress in vitro. The mechanism might be related to the inhibitory effects of EGCG on p53 induction and bcl-2 decrease.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 50 条
  • [31] Signal transducer and transcriptional activation 1 protects against pressure overload-induced cardiac hypertrophy
    Zhen, Changlin
    Liu, Hongxia
    Gao, Li
    Tong, Yuanyuan
    He, Chaoyong
    FASEB JOURNAL, 2021, 35 (01):
  • [32] TMEM173 protects against pressure overload-induced cardiac hypertrophy by modulating autophagy
    Jin, Ya-Ge
    Zhou, Heng
    Fan, Di
    Che, Yan
    Wang, Zhao-Peng
    Wang, Sha-Sha
    Tang, Qi-Zhu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (07) : 5176 - 5192
  • [33] Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction
    Fassett, John
    Xu, Xin
    Kwak, Dongmin
    Zhu, Guangshuo
    Fassett, Erin K.
    Zhang, Ping
    Wang, Huan
    Mayer, Bernd
    Bache, Robert J.
    Chen, Yingjie
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 130 : 49 - 58
  • [34] Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats
    Stenzig, Justus
    Schneeberger, Yvonne
    Loeser, Alexandra
    Peters, Barbara S.
    Schaefer, Andreas
    Zhao, Rong-Rong
    Ng, Shi Ling
    Hoeppner, Grit
    Geertz, Birgit
    Hirt, Marc N.
    Tan, Wilson
    Wong, Eleanor
    Reichenspurner, Hermann
    Foo, Roger S-Y
    Eschenhagen, Thomas
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 120 : 53 - 63
  • [35] Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats
    Wojciechowski, Peter
    Juric, Danijel
    Louis, Xavier Lieben
    Thandapilly, Sijo Joseph
    Yu, Liping
    Taylor, Carla
    Netticadan, Thomas
    JOURNAL OF NUTRITION, 2010, 140 (05): : 962 - 968
  • [36] Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats
    Rose, Madhankumar
    Balakumar, Pitchai
    Singh, Manjeet
    PHARMACOLOGY, 2007, 80 (2-3) : 177 - 184
  • [37] Sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy
    Yao, XH
    Cantor, E
    Vasanji, Z
    Greville, J
    Netticadan, T
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (04) : 636 - 636
  • [38] Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
    Xu, Si-Chi
    Ma, Zhen-Guo
    Wei, Wen-Ying
    Yuan, Yu-Pei
    Tang, Qi-Zhu
    PPAR RESEARCH, 2017, 2017
  • [39] miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy
    Yin, Xuesong
    Peng, Chenghai
    Ning, Wenhu
    Li, Chunyan
    Ren, Zhongqiao
    Zhang, Jihong
    Gao, Han
    Zhao, Kan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 379 (1-2) : 1 - 6
  • [40] Diacylglycerol kinase ζ attenuates pressure overload-induced cardiac hypertrophy
    Harada, Mutsuo
    Takeishi, Yasuchika
    Arimoto, Takanori
    Niizeki, Takeshi
    Kitahara, Tatsuro
    Goto, Kaoru
    Walsh, Richard A.
    Kubota, Isao
    CIRCULATION JOURNAL, 2007, 71 (02) : 276 - 282